Start with the thing most write-ups bury: MK-677 isn’t a peptide. Its neighbors in a research catalog are amino acid chains. This one is a single synthetic small molecule. That difference drives everything that follows, from how a solution behaves on the shelf to how you prove what’s in the vial. So “liquid” doesn’t mean much until we pin down the molecule itself.
What MK-677 is
MK-677 also goes by ibutamoren, and by its old lab code, L-163,191. On paper it’s C27H36N4O5S, mass 528.7 g/mol, PubChem CID 178024. Picture a spiroindoline bolted to a piperidine, capped with a methanesulfonyl group. Nowhere in that is a peptide bond.
That chemistry is the whole reason it exists. Merck’s team wanted a growth hormone secretagogue with no peptide in it at all, one that would stay intact in the digestive tract and keep working by the oral route. MK-677 was the answer. In their 1995 report it released growth hormone from rat pituitary cells with an EC50 of 1.3 nM, and it was active by the oral route in dogs [1].
The target is GHS-R1a, the growth hormone secretagogue receptor, cloned the following year from pituitary and hypothalamic tissue [2]. It’s the same receptor the natural hormone ghrelin uses. MK-677 is a non-peptide mimic of that signal, which our three-way MK-677 comparison puts in context against the peptide secretagogues.
Why a “liquid” at all
A small molecule like ibutamoren can be prepared as a solution, which is what “MK-677 liquid” refers to. The appeal in a lab setting is practical: a solution is ready to pipette and measure by volume, where a lyophilized powder has to be weighed and brought into solution first, with its own room for error at each step.
The catch is that a solution introduces variables a powder doesn’t. The solvent has to actually dissolve the compound and keep it dissolved. Concentration has to be right, because you’re measuring by volume now, not weighing a powder. Stability over time leans on solvent, temperature and light. Nothing exotic there. It does mean, though, that a liquid preparation lives or dies on its documentation. A powder’s identity is fixed; a solution’s concentration is a claim until something measures it.
Selectivity: the part worth checking in your own assay
Patchett’s group reported that MK-677 was fairly specific. Given by the oral route in dogs, it released growth hormone without significant changes to aldosterone, luteinizing hormone, thyroxine or prolactin, and cortisol rose only modestly [1]. For a study trying to read a clean growth hormone signal, that narrow profile is the appealing part, though it was measured in dogs and deserves checking in your own system.
One detail we always flag: that EC50 of 1.3 nM is identical to the figure reported for the peptide ipamorelin in a separate study. Different labs, different cell preparations, years apart. We wouldn’t read a direct ranking into two numbers that happen to match across papers. If the comparison matters to your work, run both compounds in one assay rather than trusting numbers stitched together from different benches. That is the only way to make an EC50 comparison mean something.
Confirming what’s in the vial
This is where the small-molecule nature pays off, because identity is clean to establish.
It also matters more than you’d think. When a 2016 analysis tested 44 products marketed online as selective androgen receptor modulators, ibutamoren turned up as an unlabeled ingredient in several of them, alongside compounds that weren’t SARMs at all [3]. In other words, MK-677 has shown up where it wasn’t claimed, and other things have shown up where MK-677 was claimed.
Analytical chemists have the molecule well characterized. A 2026 forensic study worked out detection of ibutamoren in hair down to 0.1 pg/mg, which only happens when the compound’s mass-spectrometric fingerprint is nailed down [4]. For a research vial, the same principle applies: identity by mass spectrometry and a purity figure by HPLC, tied to the exact lot, turn a label into evidence.
| Property | Value | Source |
|---|---|---|
| Class | Non-peptide small molecule | PubChem CID 178024 |
| Formula / mass | C27H36N4O5S / 528.7 g/mol | PubChem |
| Receptor | GHS-R1a (ghrelin receptor) | Howard 1996 [2] |
| In vitro potency | EC50 1.3 nM, rat pituitary cells | Patchett 1995 [1] |
| Oral activity | Active orally in dogs | Patchett 1995 [1] |
Working with MK-677 liquid
Short version: a solution is a measurement problem wearing the mask of a convenience. Confirm its concentration and identity against a certificate tied to your lot. Write down the solvent and the storage conditions. Keep a powder-form reference on hand for when a batch looks off. With a liquid, the paperwork is half the product.
For more on the compound itself, our ibutamoren MK-677 research profile covers the mechanism in depth, and our certificate of analysis guide shows what to look for on the paperwork.
References
- Patchett AA, et al. Proc Natl Acad Sci USA. 1995;92(15):7001-7005. PubMed 7624358
- Howard AD, et al. Science. 1996;273(5277):974-977. PubMed 8688086
- Van Wagoner RM, et al. JAMA. 2017;318(20):2004-2010. PubMed 29183075
- Kintz P, Gheddar L. Clin Chim Acta. 2026;578:120578. PubMed 40882886
Disclaimer: This content is intended for research purposes only and is not meant to constitute medical advice.
This educational material discusses laboratory research concepts only. Loti Labs products are intended strictly for research and development use and are not for human consumption.
